Abstract
The first NICE Guideline on Diagnosis and Management of Menopause is due to be published in November 2015. Although many guidelines, recommendations and consensus statements about menopause and treatment options have been published in the past, it is clear that this guideline will be seen as authoritative and will generate much interest and publicity both throughout the UK and further afield. We eagerly await publication, but meanwhile much work is underway to prepare for the ensuing and inevitable need for education to facilitate implementation of the recommendations.
Firstly, and most importantly, will the guideline provide women with all the information required to be able to make informed choices about the management of their menopause and their post-reproductive health at last? It is likely that many myths will be dispelled and that women will gain a better understanding of the effects and possible consequences of the menopausal transition, but reading the guideline alone will not be enough. In addition, women should have access to accurate information from which they can truly pick out what is most appropriate for their individual circumstances and needs. Through publications, media, websites, helpline, support from primary care and help from a specialist when required, this should be possible.
Secondly, are healthcare professionals in primary care ready to provide women with accurate information? It is clear that information across the UK is variable. Again, it is likely that the guideline will dispel many myths and clear some misunderstandings, particularly about risks and benefits as well as treatment duration, but further education and practical training will be required to update knowledge in individualising menopause management. Through roadshows, regional meetings, masterclasses, special skills modules, scientific conference, online training and publications, this should be possible.
Thirdly, are there many menopause specialists ready to provide advice for women with complex needs? While a number of healthcare professionals around the UK have vast experience and knowledge in the field, a ‘Menopause Specialist’ has so far not been defined but is being addressed urgently. Further, it is unlikely that all regions have access to a ‘Specialist’ and cognisance should be taken of the need for training of additional Specialists both for the immediate term and for the future.
Finally, are we ready to rekindle an interest in much needed research in post-reproductive health? It is likely that the guideline will highlight areas where further research is needed and any support for research will be welcomed. With this in mind a research fund was launched at the British Menopause Society annual conference. This fund is in its infancy, but it is hoped that even small contributions will be influential in kick-starting ideas, innovations and projects.
This is an exciting time for those of us involved in providing care for menopausal women and publication of the NICE guideline will provide us with a fantastic and unique opportunity to improve understanding for both women and healthcare professionals but also to raise awareness of the huge importance of the menopause and post reproductive health.
Are we ready? Not quite yet, but we will be!